Evidence map›Paper›PMID 32788719›Full record

ArticleNature protocols2020

Dynamic single-cell phenotyping of immune cells using the microfluidic platform DropMap.

Yacine Bounab, Klaus Eyer, Sophie Dixneuf, Magda Rybczynska, Cécile Chauvel, Maxime Mistretta, Trang Tran, Nathan Aymerich, Guilhem Chenon, Jean-François Llitjos and 14 more

Erratum issuedOpen access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature protocols, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it, 114 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. A Machine Vision Perspective on Droplet-Based Microfluidics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors at 7 institutions in 3 countries.

Yacine Bounab *BIOASTER Technology Research Institute, Lyon, France.
Klaus Eyer *Laboratoire de Colloïdes et Matériaux Divisés (LCMD), École Supérieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris Sciences et Lettres (PSL), CNRS UMR8231, Paris, France.
Sophie DixneufBiological Microsystems and Advanced Optics Engineering Unit, BIOASTER Technology Research Institute, Paris, France.
Magda RybczynskaLaboratoire de Colloïdes et Matériaux Divisés (LCMD), École Supérieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris Sciences et Lettres (PSL), CNRS UMR8231, Paris, France.
Cécile ChauvelBiological Microsystems and Advanced Optics Engineering Unit, BIOASTER Technology Research Institute, Paris, France.
Maxime MistrettaBIOASTER Technology Research Institute, Lyon, France.
Trang TranBiological Microsystems and Advanced Optics Engineering Unit, BIOASTER Technology Research Institute, Paris, France.
Nathan AymerichLaboratoire de Colloïdes et Matériaux Divisés (LCMD), École Supérieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris Sciences et Lettres (PSL), CNRS UMR8231, Paris, France.
Guilhem ChenonLaboratoire de Colloïdes et Matériaux Divisés (LCMD), École Supérieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris Sciences et Lettres (PSL), CNRS UMR8231, Paris, France.
Jean-François LlitjosMedical Intensive Care Unit, Cochin Hospital, Paris, France.
Fabienne VenetEA7426-Pathophysiology of Injury-Induced Immunosuppression, Université Claude Bernard Lyon-1 - HCL - bioMérieux, Lyon, France.
Guillaume MonneretEA7426-Pathophysiology of Injury-Induced Immunosuppression, Université Claude Bernard Lyon-1 - HCL - bioMérieux, Lyon, France.
Iain A GillespieValue, Evidence & Outcomes, GlaxoSmithKline, Stevenage, Hertfordshire, UK.
Pierre CortezR&D, Sanofi Aventis, Chilly-Mazarin, France.
Virginie MoucadelEA7426-Pathophysiology of Injury-Induced Immunosuppression, Université Claude Bernard Lyon-1 - HCL - bioMérieux, Lyon, France.
Alexandre PachotMedical Diagnostic Discovery Department (MD3), bioMérieux S.A., Lyon, France.
Alain TroeschBiological Microsystems and Advanced Optics Engineering Unit, BIOASTER Technology Research Institute, Paris, France.
Philippe LeissnerBiological Microsystems and Advanced Optics Engineering Unit, BIOASTER Technology Research Institute, Paris, France.
Julien TextorisEA7426-Pathophysiology of Injury-Induced Immunosuppression, Université Claude Bernard Lyon-1 - HCL - bioMérieux, Lyon, France.ORCID http://orcid.org/0000-0002-3821-9337
Jérôme BibetteLaboratoire de Colloïdes et Matériaux Divisés (LCMD), École Supérieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris Sciences et Lettres (PSL), CNRS UMR8231, Paris, France.
Cyril GuyardBiological Microsystems and Advanced Optics Engineering Unit, BIOASTER Technology Research Institute, Paris, France.
Jean BaudryLaboratoire de Colloïdes et Matériaux Divisés (LCMD), École Supérieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris Sciences et Lettres (PSL), CNRS UMR8231, Paris, France. jean.baudry@espci.fr.ORCID http://orcid.org/0000-0002-5526-499X
Andrew D GriffithsLaboratoire de Biochimie (LBC), École Supérieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI Paris), Université Paris Sciences et Lettres (PSL), CNRS UMR8231, Paris, France. andrew.griffiths@espci.fr.ORCID http://orcid.org/0000-0002-0808-3539
Christophe VédrineBIOASTER Technology Research Institute, Lyon, France. christophe.vedrine@bioaster.org.ORCID http://orcid.org/0000-0002-3760-3767
BIOASTER · FRCentre National de la Recherche Scientifique · FRUniversité Claude Bernard Lyon 1 · FRbioMérieux (France) · FRGlaxoSmithKline (United Kingdom) · GBHôpital Cochin · FRSanofi (France) · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Characterization of immune responses is currently hampered by the lack of systems enabling quantitative and dynamic phenotypic characterization of individual cells and, in particular, analysis of secreted proteins such as cytokines and antibodies. We recently developed a simple and robust microfluidic platform, DropMap, to measure simultaneously the kinetics of secretion and other cellular characteristics, including endocytosis activity, viability and expression of cell-surface markers, from tens of thousands of single immune cells. Single cells are compartmentalized in 50-pL droplets and analyzed using fluorescence microscopy combined with an immunoassay based on fluorescence relocation to paramagnetic nanoparticles aligned to form beadlines in a magnetic field. The protocol typically takes 8-10 h after preparation of microfluidic chips and chambers, which can be done in advance. By contrast, enzyme-linked immunospot (ELISPOT), flow cytometry, time-of-flight mass cytometry (CyTOF), and single-cell sequencing enable only end-point measurements and do not enable direct, quantitative measurement of secreted proteins. We illustrate how this system can be used to profile downregulation of tumor necrosis factor-α (TNF-α) secretion by single monocytes in septic shock patients, to study immune responses by measuring rates of cytokine secretion from single T cells, and to measure affinity of antibodies secreted by single B cells.

Indexed as

Lab-On-A-Chip DevicesPhenotypeAnimalsB-LymphocytesFemaleHumansImage Processing, Computer-AssistedImmune SystemMiceMicroscopy, FluorescenceSingle-Cell Analysis

Identifiers

PMID32788719
OpenAlexW3048393136

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.